743 related articles for article (PubMed ID: 28376502)
1. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
[TBL] [Abstract][Full Text] [Related]
5. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miR-6803-5p as potential diagnostic and prognostic marker in colorectal cancer.
Yan S; Jiang Y; Liang C; Cheng M; Jin C; Duan Q; Xu D; Yang L; Zhang X; Ren B; Jin P
J Cell Biochem; 2018 May; 119(5):4113-4119. PubMed ID: 29240249
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
10. Exosome‑encapsulated microRNA‑23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage.
Kumata Y; Iinuma H; Suzuki Y; Tsukahara D; Midorikawa H; Igarashi Y; Soeda N; Kiyokawa T; Horikawa M; Fukushima R
Oncol Rep; 2018 Jul; 40(1):319-330. PubMed ID: 29749537
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
[TBL] [Abstract][Full Text] [Related]
12. Examining plasma microRNA markers for colorectal cancer at different stages.
Sun Y; Liu Y; Cogdell D; Calin GA; Sun B; Kopetz S; Hamilton SR; Zhang W
Oncotarget; 2016 Mar; 7(10):11434-49. PubMed ID: 26863633
[TBL] [Abstract][Full Text] [Related]
13. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.
Matsumura T; Sugimachi K; Iinuma H; Takahashi Y; Kurashige J; Sawada G; Ueda M; Uchi R; Ueo H; Takano Y; Shinden Y; Eguchi H; Yamamoto H; Doki Y; Mori M; Ochiya T; Mimori K
Br J Cancer; 2015 Jul; 113(2):275-81. PubMed ID: 26057451
[TBL] [Abstract][Full Text] [Related]
14. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
16. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
17. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
Yuan D; Li K; Zhu K; Yan R; Dang C
Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
[TBL] [Abstract][Full Text] [Related]
18. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
Zhang N; Zhang PP; Huang JJ; Wang ZY; Zhang ZH; Yuan JZ; Ma EM; Liu X; Bai J
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
20. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
